Charles River Laboratories International Inc
XBER:RV6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Charles River Laboratories International Inc
XBER:RV6
|
US |
|
A
|
ACADIA Pharmaceuticals Inc
SWB:DR6
|
US |
|
B
|
BYD Co Ltd
XMUN:BY6A
|
CN |
Wall St Price Targets
RV6 Price Targets Summary
Charles River Laboratories International Inc
According to Wall Street analysts, the average 1-year price target for RV6 is 203.97 EUR with a low forecast of 137.07 EUR and a high forecast of 263.85 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV6's stock price target?
Price Target
203.97
EUR
According to Wall Street analysts, the average 1-year price target for RV6 is 203.97 EUR with a low forecast of 137.07 EUR and a high forecast of 263.85 EUR.
What is the Revenue forecast for Charles River Laboratories International Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Charles River Laboratories International Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 5 years is 15%.
